Article Details
Retrieved on: 2021-11-28 15:25:51
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
CTI BioPharma Corp.'s (NASDAQ: CTIC) NDA for pacritinib also has a PDUFA date of Tuesday, Nov. 30. Pacrotinib, if approved, is expected to address the ...
Article found on: www.benzinga.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here